维普期刊资源整合服务平台（V6.5）

373篇 您的检索式：作者名="Granger CB"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	Apixaban versus warfarin in patients with atrial fibrillation显示文摘	Granger CB Alexander JH McMurray JJ		New England Journal of Medicine0，，：	2
2	Early versus delayed invasive in- tervention in acute coronary syndromes 显示文摘	Mehta SR Granger CB Boden WE	2009	N Engl J Med2009，360，：	1
3	Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries(GUSTO 1 ) and global use of strategies to open occluded coronary arteries (GUSTO Ⅲ ) trials 显示文摘	Hudson MP Granger CB Tolol EJ	2001	Circulation2001，104，：	1
4	Effects of candesartan on mortality and morbidity in patients with chronic heart failure, the charm - overall program显示文摘	Pfeffer MA Swedberg K Granger CB	2003	Lancet2003，362，9379：	1
5	Apixaban versus warfarin in patients with atrial fibrillation显示文摘	Granger CB Alexander JH McMurray JJ	2011	N Engl J Med2011，365，11：	1
6	Effect of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme显示文摘	Pfeffer MA Swedberg K Granger CB	2003	Lancet2003，362，：	1
7	Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme 显示文摘	Pfeffer MA Swedberg K Granger CB	2003	Lancet2003，362，：	1
8	Pexelizumab,an anti-C5 complement antibody,as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction:the complement inhibition in myocardial infarction treated with angioplasty (COMMA) trial显示文摘	Mahaffey KW Weaver WD	2003	Circulation2003，108，10：	1
9	Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic function intolerant ACEI:the CHARM-Al-ternative trial显示文摘	McMurray JJV Yusuf S	2003	Lancet2003，362，：	1
10	Early versus delayed invasive intervention in acute coronary syndromes 显示文摘	Mehta SR Granger CB Boden WE	2009	N Engl J Med2009，360，21：	1
11	Effects of candesartan on mortality and morbidity in patients with chronic heart failure:the CHARM-Overall programme显示文摘	Pfeffer MA Swedberg K Granger CB	2003	Lancet2003，362，：	1
12	Prognostic value of the admission electrocardiogram in acute coronary syndromes 显示文摘	Savonitto S Ardisino D Granger CB	1999	JAMA1999，281，：	1
13	Effect of pexelizumab,an anti-C5 complement antibody,as adjunctive therapy to fibrinolysis in acute myocardial infarction:the complement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial显示文摘	Granger CB Nicolau JC	2003	Circulation2003，108，10：	1
14	APTTs after thrombolysis and standard intravenous heparin are often low and correlate with body weight , age and sex: experience from the GUSTO Trial显示文摘	Granger CB Califf RM Hirsh J Woodlief LH Topol EJ	1992	Circulation1992，86，：	1
15	Apixaban versus warfarin in patients with atrial fibriUation显示文摘	Granger CB Alexander JH McMurray JJ V	2011	N EnglJ Med2011，365，：	1
16	Apixaban versus warfarin in patients with atrial fibril- lation显示文摘	Granger CB Alexander JH MeMurray JJ	2011	N Engl J Med2011，365，11：	1
17	Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inibitors:the CHARM-Alternative显示文摘	Granger cB McMurray JJ Yusuf S at al	2003	Lancet2003，362，9386：	1
18	Early versus delayed invasive intervention in acute coronary syndromes 显示文摘	Mehta SR Granger CB Boden WE	2009	N Engl J Med2009，360，21：	1
19	Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure显示文摘	Abrahamsson P Dobson J Granger CB	2009	Eur Heart J2009，30，3：	1
20	Predictors of hospital mortality in the global registry of acute coronary events显示文摘	Granger CB Goldberg RJ Dabbous O	2003	Arch Intern Med2003，163，19：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示